These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8212841)

  • 1. Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine.
    Vafai A
    Vaccine; 1993; 11(9):937-40. PubMed ID: 8212841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein.
    Vafai A
    Vaccine; 1994 Nov; 12(14):1265-9. PubMed ID: 7531921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine.
    Vafai A
    Vaccine; 1995 Oct; 13(14):1336-8. PubMed ID: 8585290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
    Ludvíková V; Kunke D; Hamsíková E; Kutinová L; Vonka V
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1445-9. PubMed ID: 1646285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
    Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
    Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription mapping of glycoprotein I (gpI) and gpIV of varicella-zoster virus and immunological analysis of the gpI produced in cells infected with the recombinant vaccinia virus.
    Kato T; Kitamura K; Hayakawa Y; Takahashi M; Kojima A; Sato S; Yamanishi K
    Microbiol Immunol; 1989; 33(4):299-312. PubMed ID: 2549343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.
    Vafai A; Yang WN
    J Virol; 1991 Oct; 65(10):5593-6. PubMed ID: 1654454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus.
    Massaer M; Haumont M; Place M; Bollen A; Jacobs P
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():491-4. PubMed ID: 8383181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus.
    Davies J; Hallworth JA; McLeish P; Randall S; Martin BA; Buchan A; Skinner GR
    Med Microbiol Immunol; 1994 May; 183(2):105-17. PubMed ID: 7935160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes.
    Hasan UA; Harper DR; Argent S; Layton G; Wren BW; Morrow WJ
    Vaccine; 2000 Feb; 18(15):1506-14. PubMed ID: 10618548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis.
    Kimura H; Wang Y; Pesnicak L; Cohen JI; Hooks JJ; Straus SE; Williams RK
    J Infect Dis; 1998 Aug; 178(2):310-7. PubMed ID: 9697709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with Varicella-zoster virus glycoprotein E expressing vectors: Comparison of antibody response to DNA vaccine and recombinant vaccinia virus.
    Stasíková J; Kutinová L; Smahel M; Nĕmecková S
    Acta Virol; 2003; 47(1):1-10. PubMed ID: 12828337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).
    Kinchington PR; Ling P; Pensiero M; Moss B; Ruyechan WT; Hay J
    J Virol; 1990 Sep; 64(9):4540-8. PubMed ID: 2166829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neutralizing antibody responses to varicella-zoster virus glycoproteins B and E following naked DNA immunization.
    Massaer M; Haumont M; Garcia L; Mazzu L; Bollen A; Jacobs P; Jacquet A
    Viral Immunol; 1999; 12(3):227-36. PubMed ID: 10532651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of a varicella-zoster virus glycoprotein E epitope.
    Vafai A; Forghani B; Kilpatrick D; Ling J; Shankar V
    Arch Virol; 2000; 145(1):85-97. PubMed ID: 10664408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system.
    Yao Z; Jackson W; Forghani B; Grose C
    J Virol; 1993 Jan; 67(1):305-14. PubMed ID: 8380078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
    Fowler WJ; Garcia-Valcarcel M; Hill-Perkins MS; Murphy G; Harper DR; Jeffries DJ; Burns NR; Adams SE; Kingsman AJ; Layton GT
    Virology; 1995 Dec; 214(2):531-40. PubMed ID: 8553555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity.
    Murakami K; Matsuura M; Ota M; Gomi Y; Yamanishi K; Mori Y
    Vaccine; 2015 Nov; 33(45):6085-92. PubMed ID: 26116253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
    Bergen RE; Diaz PS; Arvin AM
    J Infect Dis; 1990 Nov; 162(5):1049-54. PubMed ID: 2172393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T-lymphocyte response to varicella-zoster viral proteins.
    Arvin AM; Koropchak CM; Sharp M; Bergen R; Diaz PS
    Adv Exp Med Biol; 1990; 278():71-81. PubMed ID: 1963047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.